Adnexus Therapeutics, of Waltham, Mass., appointed Martin I. Freed, chief medical officer.
Agile Therapeutics Inc., of Princeton, N.J., named Marie Foegh chief medical officer.
Alacrity Biosciences Inc., of Laguna Hills, Calif., appointed Karin Ludwig chief medical officer.
Applied Genetic Technologies Corp., of Alachua, Fla., named Jeffrey Chulay chief medical officer and vice president of regulatory affairs.
Aspreva Pharmaceuticals Corp., of Victoria, Canada, named J. William Freytag, chairman and chief executive officer.
Bavarian Nordic AS, of Kvistgard, Denmark, named Anders Hedegaard president and chief executive officer.
Cylene Pharmaceuticals, of San Diego, named David M. Ryckman vice president of manufacturing and pharmaceutical operations.
CytoCore Inc., of Chicago, appointed Floyd Taub chief executive officer.
Egalet AS, of Copenhagen, Denmark, appointed Bertrand Damour chief financial officer and executive vice president.
EnWave Corp., of Vancouver, Canada, appointed Roger W. Graham to its scientific advisory board.
Medistem Laboratories Inc., of Scottsdale, Az., appointed Scott Sullinger to its board of directors.
Medivation Inc., of San Francisco, appointed Sarvajit Chakravarty vice president of medicinal chemistry.
Mersana Therapeutics, of Cambridge, Mass., named Nicholas G. Bacopoulos to its board of directors.
Nabi Biopharmaceuticals, of Boca Raton, Fla., appointed Matthew W. Kalnik vice president of business development and project management.
Neuromed Pharmaceuticals, of Vancouver, Canada, named William L. Hunter chairman of its board of directors.
Orexigen Therapeutics Inc., of San Diego, appointed Heather Turner vice president and general counsel.
Oscient Pharmaceuticals Corp., of Waltham, Mass., named Anthony Watkins vice president of corporate development.
Resverlogix Corp., of Calgary, Canada, appointed Roger Newton to its board of directors.
Sequenom Inc., of San Diego, named Richard A. Lerner to its board of directors.
Sirtex Medical Inc., of Wilmington, Mass., named Samuel G. Putnam medical director for its U.S. operations.
Spectrum Pharmaceuticals Inc., of Irvine, Calif., named George Uy vice president of marketing for oncology and urology drugs.
StemCyte Inc., of Arcadia, Calif., appointed Robert Dickey IV senior vice president and chief financial officer.
Trius Therapeutics Inc., of San Diego, named Philippe G. Prokocimer chief medical officer.